PRDM1驱动的SLC30A9过度表达通过促进线粒体功能过高促进了宫癌细胞的恶性表型
Hui Wang1, Shuang Liu2, Ping Li3
1Department of Abdominal and Pelvic Tumor Treatment, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Cell death & disease
|December 19, 2025
概括
溶性载体家族30成员9 (SLC30A9) 通过促进线粒体功能过度促进子宫癌的进展. 向SLC30A9抑制瘤生长,为宫癌提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 线粒体高功能对于宫癌的进展至关重要.
- 溶解体载体家族30成员9 (SLC30A9),一种载体,调节线粒体的稳态和功能.
- 了解SLC30A9的作用对于宫癌研究至关重要.
研究的目的:
- 研究SLC30A9在宫癌中的表达,功能和调节机制.
- 确定SLC30A9对线粒体功能和癌细胞行为的影响.
- 确定宫癌中SLC30A9表达的关键调节者.
主要方法:
- 单细胞RNA测序和临床样本的分析.
- 使用shRNA和CRISPR/Cas9.9进行SLC30A9的淘汰/淘汰.
- 评估线粒体功能,细胞活力,增殖,迁移和亡.
- 生物信息分析,促进剂测定,染色体免疫沉 (ChIP) 和体内异种移植研究.
主要成果:
- 在宫状状细胞癌中,SLC30A9显著过度表达,与恶性瘤相关.
- 通过破坏线粒体功能,SLC30A9的枯竭会损害宫癌细胞的活力,增殖,迁移,并诱导细胞亡.
- PRDM1作为一个关键的转录因子,调节SLC30A9的表达,由ChIP测定证实.
- 在体内,SLC30A9 knockdown 抑制瘤生长,在异种移植中观察到线粒体功能障碍和亡.
结论:
- PRDM1驱动的SLC30A9过度表达促进了宫癌恶性病变,可能是通过增强的线粒体功能.
- SLC30A9代表了宫癌治疗的潜在治疗标.
- 准SLC30A9可能会破坏线粒体平衡,并抑制癌症的进展.
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:06Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K